Wound Biologics Market Size, Share & Trend Analysis Report By Product (Biological Skin Substitutes, Topical Agents), By Wound Type (Chronic, Acute), and Regional Segment Forecasts, 2015 - 2026

Published: Oct, 2019 | Pages: 108 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)

The global wound biologics market size is expected to reach USD 6.43 billion by 2026, according to a new report by Grand View Research, Inc. is expected to grow at a CAGR of 9.4% over the forecast period. The rising geriatric population, introduction of technologically advanced products, and increasing cases of burns are the key driving factors for this market.

The wound biologic therapy helps in restoring innate repair mechanisms of the patients. It also involves application of active biological agents such as plant-derived biomolecules. These biological agents has antimicrobial, anti-inflammatory attributes, and antioxidant properties that helps in rapid healing of wounds. In addition, the biologic dressing restricts water, electrolyte, protein, and heat loss and allows minimal risk of contamination. It also enables autolytic debridement and develop a granular wound bed, thereby promoting rapid wound healing.

The wound biologics treatment is very much effective in healing chronic and acute wounds. The increasing cases of burn wounds and diabetic foot ulcers across the globe are anticipated to be the major driving factor for this market growth. For instance, as per a report published by the National Center for Biotechnology Information (NCBI), in 2019, the global prevalence of Diabetic Foot Ulcers (DFU) was 6.3% in 2018 and North America reported the highest DFU prevalence rate of 13.0% and Oceania had the lowest prevalence of 3.0%. Since, wound biologics allows rapid and effective healing, thus increasing incidence of chronic wounds are expected to surge the demand for wound biologics products, thereby propelling the market growth over the forecast period.

Further key findings from the report suggest:

• In terms of revenue, acute wounds segment held the largest share in 2018 owing to the rising cases of burn wounds and trauma across the globe.

• Biological skin substitutes segment held the largest market share and is expected to witness the fastest growth rate over the forecast period owing to the increasing incidence of diabetic and venous leg ulcers across the globe.

• Hospital segment held the largest share in 2018 due to the rising cases of burns and accidents.

• Asia-Pacific is expected to witness the fastest growth over the forecast period owing to the rising number diabetic patients in this region.

• Prominent players present in the wound biologics market are Smith & Nephew PLC., Osiris Therapeutics, Integra Lifesciences, and Wright Medical

 Table of Contents

Chapter 1 Methodology and Scope
                   1.1 Market Segmentation and Scope
                       1.1.1 Estimates and forecast timeline
                   1.2 Research Methodology
                   1.3 Information Procurement
                       1.3.1 Purchased database:
                       1.3.2 GVR's internal database
                       1.3.3 Secondary sources
                       1.3.4 Primary research
                       1.3.5 Details of primary research
                   1.4 Information or Data Analysis
                       1.4.1 Data analysis models
                   1.5 Market Formulation & Validation
                   1.6 List of Secondary Sources
                   1.7 Objectives
                       1.7.1 Objective 1: Understanding market dynamics in the given countries.
                       1.7.2 Objective 2: Understanding market estimates and forecasts
                       1.7.3 Objective 3: Understanding attributes to provide elaborate details on the market structure & strategic undertakings & their impact.
                       1.7.4 Objective 4: Understanding key Product, type, and application scopes to conclude on the market size.
Chapter 2 Executive Summary
                   2.1 Market Outlook
                   2.2 Segment Outlook
Chapter 3 Wound Biologics Market Variables, Trends & Scope
                   3.1 Market Lineage Outlook
                       3.1.1 Parent market outlook
                       3.1.2 Ancillary market outlook
                   3.2 Penetration & Growth Prospect Mapping
                   3.3 Market Dynamics
                       3.3.1 Market driver analysis
                           3.3.1.1 Increasing incidence of chronic diseases
                           3.3.1.2 Rising incidences of burn injuries in developing and underdeveloped regions
                           3.3.1.3 Technological advancements
                       3.3.2 Market restraint analysis
                           3.3.2.1 High cost of wound treatment and wound care biologics
                           3.3.2.2 Risk of skin substitute failure
                   3.4 Wound Biologics: Market Analysis Tools
                       3.4.1 Industry analysis - Porter's
                       3.4.2 PESTLE analysis
Chapter 4 Wound Biologics Market: Segment Analysis, By Product, 2015 - 2026 (USD Million)
                   4.1 Definition and Scope
                   4.2 Product Market Share Analysis, 2018 & 2026
                   4.3 Segment Dashboard
                   4.4 Wound Biologics Market, by Product, 2015 to 2026
                   4.5 Market Size & Forecasts and Trend Analyses, 2015 to 2026
                       4.5.1 Biological Skin Substitutes
                           4.5.1.1 Biological Skin Substitutes Market, 2015 - 2026 (USD Million)
                           4.5.1.2 Allograft
                               4.5.1.2.1 Allograft market, 2015 - 2026 (USD Million)
                           4.5.1.3 Xenograft
                               4.5.1.3.1 Xenograft market, 2015 - 2026 (USD Million)
                           4.5.1.4 Biosynthetic Products
                               4.5.1.4.1 Biosynthetic products market, 2015 - 2026 (USD Million)
                       4.5.2 Topical Agents
                           4.5.2.1 Topical Agents Market, 2015 - 2026 (USD Million)
                       4.5.3 Collagen Dressing
                           4.5.3.1 Collagen Dressing Market, 2015 - 2026 (USD Million)
Chapter 5 Wound Biologics Market: Segment Analysis, By Wound Type, 2015 - 2026 (USD Million)
                   5.1 Definition and Scope
                   5.2 Wound Type Market Share Analysis, 2018 & 2026
                   5.3 Segment Dashboard
                   5.4 Wound Biologics Market, by Wound Type, 2015 to 2026
                   5.5 Market Size & Forecasts and Trend Analyses, 2015 to 2026
                       5.5.1 Chronic Wounds
                           5.5.1.1 Chronic Wounds Market, 2015 - 2026 (USD Million)
                       5.5.2 Acute Wounds
                           5.5.2.1 Acute Wounds Market, 2015 - 2026 (USD Million)
Chapter 6 Wound Biologics Market: Segment Analysis, By End Use, 2015 - 2026 (USD Million)
                   6.1 Definition and Scope
                   6.2 End Use Market Share Analysis, 2018 & 2026
                   6.3 Segment Dashboard
                   6.4 Wound Biologics Market, by End Use, 2015 to 2026
                   6.5 Market Size & Forecasts and Trend Analyses, 2015 to 2026
                       6.5.1 Hospitals
                           6.5.1.1 Hospitals Market, 2015 - 2026 (USD Million)
                       6.5.2 Clinics
                           6.5.2.1 Clinics Market, 2015 - 2026 (USD Million)
                       6.5.3. Others
                           6.5.3.1 Others Market, 2015 - 2026 (USD Million)
Chapter 7 Wound Biologics Market: Regional Market Analysis, By Product, Wound Type, and End Use, 2015 - 2026 (USD Million)
                   7.1 Definition & Scope
                   7.2 Regional Market Share Analysis, 2018 & 2026
                   7.3 Regional Market Dashboard
                   7.4 Regional Market Snapshot
                   7.5 North America
                       7.5.1 North America wound biologics market, 2015 - 2026 (USD Million)
                       7.5.2 U.S.
                           7.5.2.1 U.S. wound biologics market, 2015 - 2026 (USD Million)
                       7.5.3 Canada
                           7.5.3.1 Canada wound biologics market, 2015 - 2026 (USD Million)
                   7.6 Europe
                       7.6.1 Europe wound biologics market, by 2015 - 2026 (USD Million)
                       7.6.2 UK
                           7.6.2.1 UK wound biologics market, 2015 - 2026 (USD Million)
                       7.6.3 Germany
                           7.6.3.1 Germany wound biologics market, 2015 - 2026 (USD Million)
                   7.7 Asia Pacific
                       7.7.1 Asia Pacific wound biologics markeT, 2015 - 2026 (USD Million)
                       7.7.2 Japan
                           7.7.2.1 Japan wound biologics market, 2015 - 2026 (USD Million)
                       7.7.3 China
                           7.7.3.1 China wound biologics market, 2015 - 2026 (USD Million)
                   7.8 Latin America
                       7.8.1 Latin America wound biologics market,2015 - 2026 (USD Million)
                       7.8.2 Brazil
                           7.8.2.1 Brazil wound biologics market, 2015 - 2026 (USD Million)
                       7.8.3 Mexico
                           7.8.3.1 Mexico wound biologics market, 2015 - 2026 (USD Million)
                   7.9 MEA
                       7.9.1 MEA wound biologics market, 2015 - 2026 (USD Million)
                       7.9.2 South Africa
                           7.9.2.1 South Africa wound biologics market, 2015 - 2026 (USD Million)
                       7.9.3 Saudi Arabia
                           7.9.3.1 Saudi Arabia wound biologics market, 2015 - 2026 (USD Million)
Chapter 8 Wound Biologics Market - Competitive Analysis
                   8.1 Company Profiles
                       8.1.1 Smith & Nephew
                           8.1.1.1 Company overview
                           8.1.1.2 Financial performance
                           8.1.1.3 Product benchmarking
                           8.1.1.4 Strategic initiatives
                       8.1.2 Integra Lifesciences
                           8.1.2.1 Company overview
                           8.1.2.2 Financial performance
                           8.1.2.3 Product benchmarking
                           8.1.2.4 Strategic initiatives
                       8.1.3 Wright Medical
                           8.1.3.1 Company overview
                           8.1.3.2 Financial performance
                           8.1.3.3 Product benchmarking
                           8.1.3.4 Strategic initiatives
                       8.1.4 Mimedx Group
                           8.1.4.1 Company overview
                           8.1.4.2 Financial performance
                           8.1.4.3 Product benchmarking
                           8.1.4.4 Strategic initiatives
                       8.1.5 Vericel
                           8.1.5.1 Company overview
                           8.1.5.2 Financial performance
                           8.1.5.3 Product benchmarking
                           8.1.5.4 Strategic initiatives
                       8.1.6 Anika Therapeutics
                           8.1.6.1 Company overview
                           8.1.6.2 Financial performance
                           8.1.6.3 Product benchmarking
                           8.1.6.4 Strategic initiatives
                       8.1.7 Osiris Therapeutics
                           8.1.7.1 Company overview
                           8.1.7.2 Financial performance
                           8.1.7.3 Product benchmarking
                           8.1.7.4 Strategic initiatives
                       8.1.8 Kerecis
                           8.1.8.1 Company overview
                           8.1.8.2 Financial performance
                           8.1.8.3 Product benchmarking
                           8.1.8.4 Strategic initiatives
                       8.1.9 Solsys Medical
                           8.1.9.1 Company overview
                           8.1.9.2 Financial performance
                           8.1.9.3 Product benchmarking
                           8.1.9.4 Strategic initiatives

List of Tables

Table 1. Global wound biologics market, by region, 2015 - 2026 (USD Million)
Table 2. Global wound biologics market, by product, 2015 - 2026 (USD Million)
Table 3. Global wound biologics market, by wound type, 2015 - 2026 (USD Million)
Table 4. Global wound biologics market, by end use, 2015 - 2026 (USD Million)
Table 5. North America wound biologics market, by country, 2015 - 2026 (USD Million)
Table 6. North America wound biologics market, by product, 2015 - 2026 (USD Million)
Table 7. North America wound biologics market, by wound type, 2015 - 2026 (USD Million)
Table 8. North America wound biologics market, by end use, 2015 - 2026 (USD Million)
Table 9. U.S. wound biologics market, by product, 2015 - 2026 (USD Million)
Table 10. U.S. wound biologics market, by wound type, 2015 - 2026 (USD Million)
Table 11. U.S. wound biologics market, by end use, 2015 - 2026 (USD Million)
Table 12. Canada wound biologics market, by product, 2015 - 2026 (USD Million)
Table 13. Canada wound biologics market, by wound type, 2015 - 2026 (USD Million)
Table 14. Canada wound biologics market, by end use, 2015 - 2026 (USD Million)
Table 15. Europe wound biologics market, by country, 2015 - 2026 (USD Million)
Table 16. Europe wound bioogics management market, by product, 2015 - 2026 (USD Million)
Table 17. Europe wound biologics market, by wound type, 2015 - 2026 (USD Million)
Table 18. Europe wound biologics market, by end use, 2015 - 2026 (USD Million)
Table 19. UK wound biologics market, by product, 2015 - 2026 (USD Million)
Table 20. UK wound biologics market, by wound type, 2015 - 2026 (USD Million)
Table 21. UK wound biologics market, by end use, 2015 - 2026 (USD Million)
Table 22. Germany wound biologics market, by product, 2015 - 2026 (USD Million)
Table 23. Germany wound biologics market, by wound type, 2015 - 2026 (USD Million)
Table 24. Germany wound biologics market, by end use, 2015 - 2026 (USD Million)
Table 25. Asia Pacific wound biologics market, by country, 2015 - 2026 (USD Million)
Table 26. Asia Pacific wound biologics market, by product, 2015 - 2026 (USD Million)
Table 27. Asia Pacific wound biologics market, by wound type, 2015 - 2026 (USD Million)
Table 28. Asia Pacific wound biologics market, by end use, 2015 - 2026 (USD Million)
Table 29. China wound biologics market, by product, 2015 - 2026 (USD Million)
Table 30. China wound biologics market, by wound type, 2015 - 2026 (USD Million)
Table 31. China wound biologics market, by end use, 2015 - 2026 (USD Million)
Table 32. Japan wound biologics market, by product, 2015 - 2026 (USD Million)
Table 33. Japan wound biologics market, by wound type, 2015 - 2026 (USD Million)
Table 34. Japan wound biologics market, by end use, 2015 - 2026 (USD Million)
Table 35. Latin America wound biologics market, by country, 2015 - 2026 (USD Million)
Table 36. Latin America wound biologics market, by product, 2015 - 2026 (USD Million)
Table 37. Latin America wound biologics market, by wound type, 2015 - 2026 (USD Million)
Table 38. Latin America wound biologics market, by end use, 2015 - 2026 (USD Million)
Table 39. Brazil wound biologics market, by product, 2015 - 2026 (USD Million)
Table 40. Brazil wound biologics market, by wound type, 2015 - 2026 (USD Million)
Table 41. Brazil wound biologics market, by end use, 2015 - 2026 (USD Million)
Table 42. Mexico wound biologics market, by product, 2015 - 2026 (USD Million)
Table 43. Mexico wound biologics market, by wound type, 2015 - 2026 (USD Million)
Table 44. Mexico wound biologics market, by end use, 2015 - 2026 (USD Million)
Table 45. Middle East & Africa wound biologics market, by country, 2015 - 2026 (USD Million)
Table 46. Middle East & Africa wound biologics market, by product, 2015 - 2026 (USD Million)
Table 47. Middle East & Africa wound biologics market, by wound type, 2015 - 2026 (USD Million)
Table 48. Middle East & Africa wound biologics market, by end use, 2015 - 2026 (USD Million)
Table 49. South Africa wound biologics market, by product, 2015 - 2026 (USD Million)
Table 50. South Africa wound biologics market, by wound type, 2015 - 2026 (USD Million)
Table 51. South Africa wound biologics market, by end use, 2015 - 2026 (USD Million)
Table 52. Saudi Arabia wound biologics market, by product, 2015 - 2026 (USD Million)
Table 53. Saudi Arabia wound biologics market, by wound type, 2015 - 2026 (USD Million)
Table 54. Saudi Arabia wound biologics market, by end use, 2015 - 2026 (USD Million)

List of Figures

Fig. 1 Wound biologics market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2018)
Fig. 10 Segment outlook
Fig. 11 Strategy framework
Fig. 12 Wound biologics market lineage
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Consumer behavior analysis
Fig. 15 Factors influencing wound biologics market (%)
Fig. 16 Market driver relevance analysis (Current & future impact)
Fig. 17 Market restraint relevance analysis (Current & future impact)
Fig. 18 Market challenge relevance analysis (Current & future impact)
Fig. 19 Porter's five forces analysis
Fig. 20 PESTLE analysis
Fig. 21 Wound biologics market: product movement analysis
Fig. 22 Segment dashboard
Fig. 23 Wound biologics market product outlook: Key takeaways
Fig. 24 Biological skin substitutes market, 2015 - 2026 (USD Million)
Fig. 25 Allograft market, 2015 - 2026 (USD Million)
Fig. 26 Xenograft market, 2015 - 2026 (USD Million)
Fig. 27 Biosynthetic products market, 2015 - 2026 (USD Million)
Fig. 28 Wound biologics market: wound type movement analysis
Fig. 29 Segment dashboard
Fig. 30 Wound biologics market wound type outlook: Key takeaways
Fig. 31 Chronic market, 2015 - 2026 (USD Million)
Fig. 32 Acute wounds market, 2015 - 2026 (USD Million)
Fig. 33 Wound biologics market: end use movement analysis
Fig. 34 Segment dashboard
Fig. 35 Wound biologics market end use outlook: Key takeaways
Fig. 36 Hospitals market, 2015 - 2026 (USD Million)
Fig. 37 Clinics market, 2015 - 2026 (USD Million)
Fig. 38 Others market, 2015 - 2026 (USD Million)
Fig. 39 Regional outlook, 2018 & 2026
Fig. 40 Regional market dashboard
Fig. 41 North America wound biologics market, 2015 - 2026 (USD Million)
Fig. 42 U.S. wound biologics market, 2015 - 2026 (USD Million)
Fig. 43 Canada wound biologics market, 2015 - 2026 (USD Million)
Fig. 44 Europe wound biologics market, 2015 - 2026 (USD Million)
Fig. 45 UK. wound biologics market, 2015 - 2026 (USD Million)
Fig. 46 Germany wound biologics market, 2015 - 2026 (USD Million)
Fig. 47 Asia Pacific wound biologics market, 2015 - 2026 (USD Million)
Fig. 48 Japan wound biologics market, 2015 - 2026 (USD Million)
Fig. 49 China wound biologics market, 2015 - 2026 (USD Million)
Fig. 50 Latin America wound biologics market, 2015 - 2026 (USD Million)
Fig. 51 Brazil wound biologics market, 2015 - 2026 (USD Million)
Fig. 52 Mexico wound biologics market, 2015 - 2026 (USD Million)
Fig. 53 MEA wound biologics market, 2015 - 2026 (USD Million)
Fig. 54 South Africa wound biologics market, 2015 - 2026 (USD Million)
Fig. 55 Saudi Arabia wound biologics market, 2015 - 2026 (USD Million)